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Abstract
Loci identified in genome-wide association studies (GWAS) can include multiple distinct
association signals. We sought to identify the molecular basis of multiple association signals
for adiponectin, a hormone involved in glucose regulation secreted almost exclusively from
adipose tissue, identified in the Metabolic Syndrome in Men (METSIM) study. With GWAS
data for 9,262 men, four loci were significantly associated with adiponectin: ADIPOQ,
CDH13, IRS1, and PBRM1. We performed stepwise conditional analyses to identify distinct
association signals, a subset of which are also nearly independent (lead variant pairwise
r2<0.01). Two loci exhibited allelic heterogeneity, ADIPOQ and CDH13. Of seven association signals at the ADIPOQ locus, two signals colocalized with adipose tissue expression
quantitative trait loci (eQTLs) for three transcripts: trait-increasing alleles at one signal were
associated with increased ADIPOQ and LINC02043, while trait-increasing alleles at the
other signal were associated with decreased ADIPOQ-AS1. In reporter assays, adiponectin-increasing alleles at two signals showed corresponding directions of effect on transcriptional activity. Putative mechanisms for the seven ADIPOQ signals include a missense
variant (ADIPOQ G90S), a splice variant, a promoter variant, and four enhancer variants. Of
two association signals at the CDH13 locus, the first signal consisted of promoter variants,
including the lead adipose tissue eQTL variant for CDH13, while a second signal included a
distal intron 1 enhancer variant that showed ~2-fold allelic differences in transcriptional
reporter activity. Fine-mapping and experimental validation demonstrated that multiple,
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Adiponectin GWAS loci harboring extensive allelic heterogeneity exhibit distinct molecular consequences

distinct association signals at these loci can influence multiple transcripts through multiple
molecular mechanisms.

Author summary
Many DNA variants affect common human traits, and distinct variants can have different
effects on the function or expression level of the same gene. We identified variants associated with levels of adiponectin, a hormone involved in glucose regulation. Among these
variants, we specifically studied the sets of variants located near two genes, ADIPOQ and
CDH13, to determine how the variants affect gene expression or function. We focused on
sets of variants that can be inherited together but are not always inherited together. Of the
variants associated with adiponectin and located near ADIPOQ, one set were also associated with higher expression levels of the protein-coding ADIPOQ gene and a nearby noncoding gene, a second set of variants were associated with lower levels of the ADIPOQAS1 antisense gene, and additional variants changed the amino acid sequence or size of
the adiponectin protein. Our examples show the benefits of identifying multiple sets of
trait-associated variants in the same DNA region. These variants explain more trait variation, help identify genes that affect the trait, and guide studies of gene regulation and biological processes.

Introduction
Genome-wide association studies (GWAS) have identified thousands of associations between
genomic loci and complex traits[1, 2]. However, identification of mechanisms underlying the
association signals is often complicated by numerous potential target genes and patterns of
linkage disequilibrium (LD)[3]. The complexity of GWAS loci also includes the consequences
of allelic heterogeneity[4]. At loci harboring allelic heterogeneity, multiple functional variants
can result in multiple distinct association signals. Depending on the haplotype on which each
new functional variant allele arose[5], lead variants at these signals may exhibit moderate pairwise LD or may be nearly independent (r2<0.01). Allelic heterogeneity can include both cisregulatory and coding variants that may act alone or in combination to affect the phenotype
[6]. With increasing sample sizes and use of larger imputation reference panels in array- and
sequence-based GWAS, the extent of allelic heterogeneity at complex trait loci is becoming
more apparent[7]. This heterogeneity creates challenges in identifying causal variants and target genes, but also leads to more comprehensive characterization of mechanisms by which
GWAS variants influence the associated trait(s).
Interpretation of GWAS results includes elucidating the molecular mechanisms by which
genetic variants affect gene expression or function. Early candidate gene and genome-wide
association studies identified multiple coding variants associated with a complex trait within
the same gene[8–10]. Other studies have reported loci where multiple regulatory variants in
strong LD with each other likely affect one gene[11, 12], loci where multiple regulatory variants may affect different genes[13], and loci for which both coding and noncoding variants in
the same region are independently associated with a phenotype[5, 14]. Examples of the dissection and characterization of multiple, distinct, cis-regulatory association signals at one locus
remain few[11, 15, 16], especially when the signals are not statistically independent of each
other.
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To detect and characterize the molecular mechanisms at GWAS loci harboring allelic heterogeneity, we tested genetic associations with circulating plasma adiponectin levels in the
Metabolic Syndrome in Men (METSIM) study. Adiponectin, encoded by the ADIPOQ gene, is
a hormone involved in glucose regulation and secreted almost exclusively by adipose tissue
[17]. We identified additional association signals within 1 Mb of significant lead GWAS
variants (P<5x10-8) using stepwise conditional analyses. To identify candidate functional
variant(s) and gene(s) at these association signals, we used coding annotations, colocalized adipose expression quantitative trait locus (eQTL) signals, chromatin accessibility, and epigenomic marks of transcriptional regulation, and demonstrated allelic effects of variants on
regulatory activity in functional assays. Taken together, this study demonstrates that independent and distinct association signals within one locus may affect different transcripts and act
via multiple distinct molecular mechanisms.

Results
Genetic variants associated with adiponectin levels
We conducted a genome-wide association study (GWAS) for adiponectin levels in 9,262 nondiabetic men from the METSIM study[18]. We assumed an additive genetic model and tested
for association with ~16.6 million variants with MAF � 0.08% (minor allele count � 15). We
confirmed (P<0.05) twelve adiponectin loci previously identified in European and East Asian
individuals (S1 Table), four of which achieved genome-wide significance (rs12051272 within
CDH13 intron 1, P = 1.8 x 10−68; rs199938283 near ADIPOQ, P = 8.2 x 10−55; rs149689033, 630
kb upstream of IRS1, P = 3.0 x 10−9; and rs2276824 within an intron of PBRM1, P = 3.5 x 10−8;
Table 1; S2 Table; S1–S5 Figs). One previously unreported locus, located 454 kb downstream
of EPHA3 (rs139269730, P = 4.1 x 10−8; S6 Fig) showed nominal genome-wide significance,
although the single lead variant exhibited only moderate imputation quality (r2 = 0.74) and
may represent a false positive. Assuming the fifth signal is a false positive, the four other lead
GWAS signals explained 7.0% of variation in adiponectin levels.
Table 1. Loci with two or more distinct signals of adiponectin association detected using stepwise conditional analysis (locus-wide significance, P<1x10-5).
Lead variant

Chr:Position (hg19)

EA/NEA

EAF

EA count

LD (r2/D’)a

Unconditioned GWAS
Effect (SE)

P

-0.653 (0.042)

8.2x10-55

-0.130 (0.015)

-17
-22
-10
-5

-45
-3

Conditioned GWAS
Effect (SE)

P

-

-

-0.193 (0.015)

1.3x10-35

0.311 (0.045)

4.9x10-12

0.115 (0.019)

3.8x10-9

-0.983 (0.190)

2.4x10-7

-0.161 (0.031)

2.8x10-7

-0.856 (0.251)

6.5x10-4

-

-

0.084 (0.015)

3.2x10-8

ADIPOQ
rs199938283 (A)
rs4632532 (B)
rs16861209 (C)
rs73187787 (D)
rs17366653 (E)
rs17846866 (F)
rs62625753 (G)

3:186,552,469
3:186,551,682
3:186,563,114
3:186,701,595
3:186,570,816
3:186,570,746

C/CAAAT
C/T
A/C
T/C
C/T
G/T

0.03
0.40
0.03
0.18
0.002
0.09

3:186,572,026

A/G

0.0008

16:82,663,288

T/G

0.11

596
11,090
532
3,340
29
1,647
15

0.04/0.95
0.00/1.00
0.01/0.88
0.00/1.00
0.31/0.95

0.435 (0.045)
0.126 (0.020)
-0.848 (0.195)
-0.373 (0.026)

1.5x10
2.2x10
1.9x10

1.4x10
4.5x10

0.00/1.00

-0.766 (0.258)

3.0x10

-

-0.430 (0.024)

1.8x10-68

0.119 (0.015)

-15

CDH13
rs12051272 (A)
rs4782722 (B)

16:82,672,165

T/G

0.46

1,979
10,047

0.02/0.41

6.8x10

Chr, chromosome; EA, effect allele; NEA, non-effect allele; EAF, effect allele frequency; GT, genotyped; LD, linkage disequilibrium; SE, standard error
a
LD (r2/D’) with variant showing the strongest evidence of association at each locus.
Effect size from an additive model and corresponding to the effect allele for inverse-normal transformed adiponectin levels. P values of stepwise conditional analyses, in
which we included the variant(s) with the strongest evidence of association into the regression model as a covariate(s) and continued to test for the next strongest
variant until the strongest variant showed a conditional P value >1x10-5 or had been reported as a functional variant (ADIPOQ signal G, rs62625753; Gly90Ser).
https://doi.org/10.1371/journal.pgen.1009019.t001
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At these four loci, we identified additional association signals by performing stepwise conditional analyses and, for comparison, an approximate conditional analysis. We defined “distinct” as an association signal that met a locus-wide significance threshold of Pcond<1x10-5
within 1 Mb of an initial lead GWAS variant after conditioning. When the pairwise linkage
disequilibrium (LD) between the signal’s lead variant and all other identified lead variants at
the locus was low (r2<0.01), we defined the signal more specifically as “independent”. Only
one association signal was identified at the IRS1 and PBRM1 loci (S2 Table and S4–S6 Figs).
We identified additional association signals at both the ADIPOQ (seven total signals) and
CDH13 (two total signals) loci, described in more detail below. After adding the seven additional signals identified at the ADIPOQ and CDH13 loci, the four loci explained 10.3% of the
variation in adiponectin levels.

Four independent and three distinct association signals at ADIPOQ
ADIPOQ encodes the adiponectin protein measured in GWAS and is expressed almost exclusively in mature adipocytes[19]. At the ADIPOQ locus, stepwise conditional analysis revealed
seven distinct signals associated with adiponectin levels (Table 1; S2 and S3 Tables; Fig 1; S3
and S7 Figs). After conditioning on the lead GWAS variant (rs199938283; signal ‘A’), the next
strongest adiponectin-associated variant was rs4632532 (Pcond = 1.3x10-35; signal ‘B’). Variants
at signal ‘B’ were previously reported by the ADIPOGen GWAS meta-analysis to have the
strongest association with adiponectin levels. However, studies contributing to that analysis
were imputed to the HapMap2 reference panel, which did not include any variants representing signal ‘A’[20]. Our subsequent conditional analyses identified four additional association
signals (lead variants rs16861209, signal ‘C’; rs73187787, signal ‘D’; rs17366653, signal ‘E’; and
rs17846866, signal ‘F’; Table 1) that each reached locus-wide significance (P<1x10-5). The next
strongest signal (rs62625753, signal ‘G’) did not meet the significance threshold but is a known
missense variant in exon 3 of ADIPOQ (G90S; Table 1) shown previously to influence adiponectin multimerization[21]. No additional coding variants within the ADIPOQ gene reached
the locus-wide significance threshold for association with adiponectin levels (S4 Table). Altering the order by which variants were entered into the model as covariates did not alter the lead
variants at any association signal, nor did selection of a different variant to represent a particular association signal or use of a different initial imputation reference panel (S5 Table).
Together, the seven signals explained 5.8% of the phenotypic variance compared to 2.7% for
the lead ADIPOQ signal alone.
To characterize the distinct signals, we examined the LD between lead variants at pairs of
signals. We found the pairwise LD to be low (r2�0.01) for all signal pairs except for signals ‘A’
and ‘B’ (r2 = 0.05) and signals ‘A’ and ‘F’ (r2 = 0.33), suggesting that signals ‘C’, ‘D’, ‘E’, and ‘G’
are statistically near-independent, while signals ‘A’, ‘B’, and ‘F’ are distinct, yet the trait-raising
alleles are sometimes present on shared haplotypes. To determine the extent to which the three
signals act independently of each other, we next performed haplotype association analyses
with adiponectin levels in METSIM using the lead variants from signals ‘A’, ‘B’, and ‘F’ (S8
Fig). Compared to a reference haplotype containing the adiponectin-increasing alleles at both
signals ‘A’ and ‘B’ (rs199938283-Ins and rs4632532-T), haplotypes containing at least one adiponectin-decreasing allele exhibited lower adiponectin levels (e.g. Ins-C, β = -0.193; CT, β =
-0.779; S8A Fig). A similar pattern of association was observed between signals ‘A’ and ‘F’ (S8B
Fig). These results confirm that within haplotypes with the same allele at signal ‘A’, variants at
both signals ‘B’ and ‘F’ still contribute to variation in adiponectin levels.
We extended the haplotype association analyses with adiponectin levels to use the lead variants for all seven signals (S9 and S10 Figs). Compared to a reference haplotype containing the
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Fig 1. Locus with seven adiponectin GWAS signals and subcutaneous adipose eQTL signals for three transcripts. (A) Seven signals near
ADIPOQ (labeled ‘A’-‘G’) were identified through stepwise conditional analyses for association with adiponectin levels (n = 9,262). The signals are
labeled in the order in which they were identified in the stepwise process and are distinguished by both color and shape. Variants are shaded based
on LD with the lead variants, shown as diamonds. (B) Two variants in perfect LD (r2 = 1.00) with adiponectin GWAS signal ‘A’ (rs76786086 and
rs115527175) show the strongest association with expression levels of ADIPOQ and LINC02043 in subcutaneous adipose tissue in 434 METSIM
participants. The strongest adiponectin-associated variant from signal ‘F’ (rs17846866) also shows the strongest association with expression levels of
ADIPOQ-AS1 in subcutaneous adipose tissue in 434 METSIM participants.
https://doi.org/10.1371/journal.pgen.1009019.g001

PLOS Genetics | https://doi.org/10.1371/journal.pgen.1009019 September 11, 2020

5 / 25

PLOS GENETICS

Adiponectin GWAS loci harboring extensive allelic heterogeneity exhibit distinct molecular consequences

adiponectin-increasing alleles at each signal (rs199938283-Ins, rs4632532-T, rs16861209-A,
rs73187787-T, rs17366653-T, rs17846866-T, and rs62625753-G), haplotypes containing at
least one adiponectin-decreasing allele exhibited lower adiponectin levels (e.g. Ins-TACTTG,
β = -0.043; Ins-TCTTTG, β = -0.278). Haplotypes containing the largest number of adiponectin-decreasing alleles exhibited the lowest levels of adiponectin when compared to the baseline
haplotype. To account for potential errors in chromosome phasing, we repeated haplotype
analyses using only the 2,637 METSIM participants homozygous for all seven signals; estimated effect sizes were consistent with those based on the full set of participants (S10 Fig), providing support that our estimated effect size estimates are not influenced by haplotyping
errors.

Multiple candidate transcripts at ADIPOQ
We next examined molecular mechanisms at the ADIPOQ locus, including variants in ADIPOQ predicted to affect the adiponectin protein (Table 2). Signals ‘E’ and ‘G’ showed the largest effects on adiponectin levels (Table 1), and both have been shown previously to alter
ADIPOQ protein sequence. rs62625753 at signal ‘G’ encodes Gly90Ser, which decreases adiponectin multimerization[21]. Because we measured total adiponectin, we do not have data on
Table 2. Proposed molecular consequences at multi-signal loci.
Signal

Lead variant and
Number of
adiponectin-decreasing candidate variants
allele
(r2�0.80)

Candidate functional variant(s)
based on allelic differences in
experimental assays

Candidate transcript and
direction based on
colocalized eQTL

Putative molecular consequence

ADIPOQ
A

rs199938283-C

15

rs76071583

# ADIPOQ, # LINC02043

Decreased ADIPOQ and LINC02043
enhancer activity; decreased
transcriptional activity (Fig 2)

B

rs4632532-C

14

-

-

Assumed decreased ADIPOQ enhancer
activity

C

rs16861209-C

12

-

-

Assumed decreased ADIPOQ enhancer
activity

D

rs73187787-C

7

rs13322149, rs55958900

-

Increased distal enhancer ADIPOQ-AS1
activity; increased transcriptional activity
(Fig 2)

E

rs17366653-C

1

rs17366653

-

ADIPOQ splice variant; reported to
increase the proportion of ADIPOQ
isoform lacking exon 2 and 3 [22]

F

rs17846866-G

2

-

" ADIPOQ-AS1

Assumed increased ADIPOQ-AS1
enhancer activity

G

rs62625753-A

1

rs62625753 (Gly90Ser)

-

ADIPOQ missense variant (G90S);
reported to decrease adiponectin
multimerization[21]

A

rs12051272-T

8

rs12051272

" CDH13

B

rs4782722-G

6

rs4782722

-

CDH13
Decreased CDH13 proximal intron 1
promoter activity (Fig 4, S17 Fig)
CDH13 distal intron 1 enhancer activity;
increased transcriptional activity (Fig 4,
S17 Fig)

For candidate transcripts and putative molecular consequences, the directions of effect are based on the allele associated with decreased adiponectin levels in the
METSIM GWAS. The putative molecular consequence column includes allele-specific functional evidence from this work and other cited publications. When no direct
evidence exists for molecular consequences of a variant (CDH13 signal ‘A’ and ADIPOQ signals ‘B’, ‘C’, and ‘F’), we proposed molecular functions and candidate
transcript based on candidate variant locations.
https://doi.org/10.1371/journal.pgen.1009019.t002
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multimers to validate the functional consequences shown previously. rs17366653 at signal ‘E’
was reported to increase the proportion of ADIPOQ isoform that splices out exons 2 and 3 (50
bp), leading to nonsense-mediated decay[22]. We did not have a sufficient number of study
participants in the RNA-seq data that expressed the ADIPOQ isoform without exons 2 and 3
to examine the association between rs17366653 and expression level of the isoform.
To aid in the identification of candidate genes, we examined whether the association signals
for adiponectin are colocalized (see Methods) with association signals for expression levels of
nearby (<1 Mb) transcripts in subcutaneous adipose tissue from a subset of 434 METSIM participants (S6 Table)[23]. Adiponectin association signal ‘A’ colocalized with eQTL signals for
ADIPOQ (rs76786086-T; β = -1.69; P = 1.0x10-9) and LINC02043 (rs115527175-T; β = -1.19;
P = 1.9x10-5), an adjacent long non-coding RNA expressed primarily in brain, adipose, testis,
arterial, and splenic tissues (Table 2; S6 and S7 Tables; Fig 1B; S11 Fig). Additionally, adiponectin association signal ‘F’ colocalized with an eQTL signal for ADIPOQ-AS1 (β = 0.77;
P = 7.7x10-10), an antisense transcript overlapping portions of two distal exons of ADIPOQ
that has been shown to post-transcriptionally regulate ADIPOQ (S6 and S7 Tables; Fig 1B; S11
Fig)[24]. No additional eQTL signals were detected for these three transcripts, and no other
colocalized cis-eQTL associations were identified for these variants (S7 Table). Variants associated with lower plasma adiponectin level at signal ‘A’ were associated with lower expression
levels of both ADIPOQ and LINC02043, while variants associated with lower plasma adiponectin level at signal ‘F’ were associated with higher expression level of ADIPOQ-AS1 (S12 Fig).
Expression levels of ADIPOQ and ADIPOQ-AS1 are only weakly positively correlated, potentially reflecting the very low relative expression level of ADIPOQ-AS1 and the wide distribution
of expression level of ADIPOQ. In comparison, data from GTEx v8[25] showed different lead
variants associated with expression level of ADIPOQ that correspond to GWAS signal ‘F’ and
of ADIPOQ-AS1 that correspond to GWAS signal ‘E’; these results may be influenced by differences in cell type composition, sex, sampling variability, and/or expression measurement/
analysis (S8 Table).
We further investigated signals ‘A’ and ‘F’ at the ADIPOQ locus to evaluate their statistically
distinct contributions to gene expression. Within the METSIM adipose eQTL data, we used
further conditional analyses to investigate whether the associations between signals ‘A’ and ‘F’
and expression levels of ADIPOQ and ADIPOQ-AS1 may have different molecular effects
(S9 Table). The association between signal ‘A’ variant rs143784260 (LD r2 = 1.00 with lead signal ‘A’ variant rs199938283) and ADIPOQ expression level persists after conditioning on signal
‘F’ variant rs17846866 (Pinitial = 1.0x10-9; Pcond = 1.3x10-6). Similarly, the association between
signal ‘F’ variant rs17846866 and ADIPOQ-AS1 expression level persists after conditioning on
signal ‘A’ variant rs143784260 (Pinitial = 7.6x10-10; Pcond = 5.6x10-12). The distinct contributions
of each signal on transcript expression were confirmed using haplotype association analyses
(S13 Fig). Compared to the reference haplotypes containing the transcript expression-increasing alleles at both ADIPOQ (rs143784260-C, rs17846866-T) and ADIPOQ-AS1 (rs143784260C, rs17846866-G), haplotypes containing at least one transcript expression-decreasing allele
exhibited lower expression levels, providing further support that these two association signals
have molecularly distinct effects.

Candidate regulatory variants at ADIPOQ
Based on the position of signal ‘A’ and ‘B’ candidate variants in accessible chromatin and chromatin marks of active enhancers in adipocytes/adipose tissue, we tested variants for allelic
effects on transcriptional activity (Fig 2; S14 Fig). Of 14 candidate variants at signal ‘A’ (lead
GWAS variant and variants in LD r2�0.80), rs76071583, in a 462-base pair element located
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Fig 2. ADIPOQ signals ‘A’ and ‘D’ exhibit allelic differences in transcriptional activity. (A) rs199938283 and thirteen candidate variants in high pairwise LD
(r2�0.80) span a 25 kb region upstream of the ADIPOQ transcription start site and within ADIPOQ intron 1. (B) rs76071583-A, associated with higher adiponectin
levels, showed greater transcriptional activity in both forward and reverse orientation with respect to ADIPOQ in 3T3L1 differentiated adipocytes compared to
rs76071583-G and an “empty vector” containing a minimal promoter. (C) rs73187787 and six candidate variants in high pairwise LD (r2�0.80) span a 10 kb region
within ST6GAL1 intron 2. (D) A haplotype of variant alleles rs13322149-G and rs55958900-A, associated with lower adiponectin levels, showed greater
transcriptional activity in both forward and reverse orientation in 3T3L1 differentiated adipocytes compared to the TC haplotype and an “empty vector”
containing a minimal promoter.
https://doi.org/10.1371/journal.pgen.1009019.g002

~2.5 kb upstream from the ADIPOQ transcription start site (Fig 2A), showed the strongest
allelic differences in transcriptional activity. In differentiated 3T3-L1 adipocytes, the element
containing the adiponectin-increasing allele rs76071583-A showed 2.5-fold increased
enhancer activity compared to the element containing the rs76071583-G allele (forward,
P<0.0001; reverse, P = 0.0003; Fig 2B), suggesting that the alleles alter function of a cis-regulatory enhancer element. The sequence containing rs76071583-A is predicted to include a consensus core-binding motif for CEBP-α, and a ChIP-seq peak for CEBP-α also overlaps this
region. In electrophoretic mobility shift assays (EMSA) using CEBP-α protein, we observed an
allele-specific band for rs76071583-A (S15 Fig), suggesting that CEBP-α binds to rs76071583
to increase enhancer activity at this locus. Additional variants tested representing signals ‘A’
and ‘B’ did not exhibit allelic differences in transcriptional activity (S14 Fig). These and other
variants representing signals ‘B’ and ‘C’ are interspersed in chromosomal position with
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variants from signal ‘A’. However, we did not observe any strong annotations of regulatory elements (S7 Fig) and the functional consequences of signals ‘B’ and ‘C’ remain to be detected.
Of candidate variants at ADIPOQ signal ‘D’, we examined transcriptional activity in
reporter assays for a 445-base pair region spanning rs13322149 and rs55958900 located 135 kb
distal to the ADIPOQ promoter within the first intron of ST6GAL1 (Fig 2C). In differentiated
3T3-L1 cells, the haplotype containing both alleles associated with lower adiponectin
(rs13322149-G and rs55958900-A) exhibited � 2.4-fold higher enhancer activity (forward,
P = 0.012; reverse, P = 0.009) compared to the haplotype containing the alleles associated with
higher adiponectin (Fig 2D), suggesting that one or both variants within this haplotype alter a
distal cis-regulatory element. While we do not have direct mechanistic evidence of a link to
any transcript, the direction of effect of adiponectin decreasing alleles on transcriptional activity is consistent with an effect on ADIPOQ-AS1, not ADIPOQ or LINC02043. The allelic effects
on transcriptional activity, distance (>100 kb) from the other signals, and direction of effect
consistent with ADIPOQ-AS1 all provide support for functional consequences molecularly distinct from the other signals.

Two association signals at CDH13
Expressed in multiple cell types throughout the cardiovascular system, CDH13 encodes the
cadherin-13 receptor, a cell surface receptor for hexameric and high-molecular weight adiponectin known to influence levels of circulating adiponectin[26]. Positive feedback exists
between adiponectin and the cadherin-13 receptor[27]. At the CDH13 locus, we identified two
distinct adiponectin association signals. Conditioning on the lead GWAS variant (rs12051272,
signal ‘A’) revealed a second distinct signal (rs4782722, Pcond = 3.2x10-8, signal ‘B’) (Table 1; S2
Table; Fig 3A; S2 Fig). Pairwise LD between the lead variants at the two signals was low (r2 =
0.04). No CDH13 coding variants reached locus-wide significance with adiponectin levels after
conditioning on rs12051272 and rs4782722 (S10 Table). Compared to a reference haplotype
containing the adiponectin-increasing allele at both variants (rs12051272-G and rs4782722-T),
haplotypes containing at least one adiponectin-decreasing allele exhibited lower adiponectin
levels (GG, β = -0.072; TT, β = -0.381; Fig 3D). Haplotypes containing both adiponectindecreasing alleles exhibited the lowest levels of adiponectin (TG, β = -0.494) when compared
to the baseline haplotype. Together, the two signals explained 3.8% of the variance in adiponectin levels compared to 3.5% for the lead CDH13 signal alone.

Function of candidate regulatory variants at CDH13
We next tested the CDH13 signals for colocalization with subcutaneous adipose eQTL signals
for nearby transcripts. The adiponectin-decreasing allele rs2239857-G, a variant in perfect LD
(r2 = 1.0) with the lead adiponectin GWAS variant of signal ‘A’ (rs12051272; r2 = 1.00), is most
strongly associated with increased CDH13 expression level (β = 1.00; P = 4.35x10-26; Table 2;
S6 Table; Fig 3E). While we did not find significant evidence of a second signal associated with
expression level of CDH13 or colocalizations with expression level of any other transcripts,
larger eQTL studies would have more power to detect additional signals.
To investigate whether the two statistically distinct adiponectin-association signals at
CDH13 have distinguishable consequences, we investigated potential molecular mechanisms.
At both signals, no candidate variants (LD r2�0.80 with rs12051272 or rs4782722) are located
in coding regions. The lead signal ‘A’ variant rs12051272, is located in intron 1, ~3 kb from the
CDH13 transcription start site, in an accessible chromatin region with chromatin marks of
active enhancers in multiple cell types including HeLa (Fig 4A and 4B; S16 Fig). We used
HeLa cells to examine transcriptional activity in reporter assays for a 775-bp region spanning
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Fig 3. Locus with two adiponectin GWAS signals and one subcutaneous adipose eQTL signal for CDH13. (A) The first signal with lead
variant rs12051272 (red circles, denoted as ‘A’) shows the strongest association in the adiponectin GWAS (n = 9,262). After conditioning on
rs12051272, a second signal with lead variant rs4782722 (blue triangles, denoted as ‘B’) remained significant (P<5x10-8). Variants are shaded
based on LD with the lead variants, shown as diamonds. (B) rs12051272 (purple diamond; signal ‘A’) shows the strongest association with
adiponectin. (C) rs4782722 (purple diamond; signal ‘B’) shows the strongest association with adiponectin after conditioning on rs12051272
(signal ‘A’). (D) Haplotypes of rs12051272 and rs4782722 estimated from 9,262 METSIM participants. Alleles associated with higher adiponectin
levels in single variant analyses are shown in green, alleles associated with lower adiponectin are shown in purple. Haplotype association was
performed with adiponectin inverse normalized residuals after adjusting for age, age2, and BMI using the most frequent haplotype as the
reference. (E) Variant rs2239857, in perfect LD (r2 = 1.00) with rs12051272, shows the strongest association with expression level of CDH13 in
subcutaneous adipose tissue in 434 METSIM participants.
https://doi.org/10.1371/journal.pgen.1009019.g003
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Fig 4. Both GWAS signals at CDH13 (signals ‘A’ and ‘B’) exhibit allelic differences in transcriptional activity. (A) rs12051272 is located within CDH13 intron
1. (B) rs12051272-G associated with lower adiponectin showed greater transcriptional activity in the forward orientation with respect to CDH13 in HeLa cells
compared to rs12051272-G and an “empty vector” containing a minimal promoter. (C) rs4782722 and all five candidate variants in high pairwise LD (r2�0.80)
span a 2.5 kb region in CDH13 introns 1 and 2. (D) A haplotype of variant alleles rs4782722-G and rs12444113-G associated with lower adiponectin showed greater
transcriptional activity in both forward and reverse orientation with respect to CDH13 in HeLa cells compared to the TC haplotype and an “empty vector”
containing a minimal promoter. Transcriptional activity results for rs3910232 are shown in S18 Fig.
https://doi.org/10.1371/journal.pgen.1009019.g004

rs12051272 (Fig 4A and 4B). The adiponectin-increasing allele rs12051272-G showed an average of 1.7-fold increased enhancer activity compared to the rs12051272-T (P = 0.004), suggesting that rs12051272-G may be responsible for increased transcriptional activity of a target gene
leading to higher adiponectin levels. The rs12051272-G allele that showed increased enhancer
activity in HeLa cells was unexpectedly associated with decreased CDH13 adipose tissue
expression levels, suggesting that the effect observed in HeLa cells does not fully represent the
adipose tissue signal, that CDH13 expression level reflects feedback[27, 28], or that CDH13 is
not the target gene.
At CDH13 signal ‘B’, we investigated three intronic variants located ~12 kb distal to the
CDH13 transcription start site in accessible chromatin regions with marks of active enhancers
(rs4782722, rs12444113, and rs3910232; Fig 4C and 4D; S17 and S18 Figs). In HeLa cells, a
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398-bp region containing the adiponectin-decreasing alleles of two variants (rs4782722-G and
rs12444113-G) showed 1.7-fold increased enhancer activity compared to the haplotype containing the non-risk alleles (P = 0.0001). Additional haplotype constructs containing
rs4782722-G showed a 1.4-fold increase in enhancer activity compared to haplotype constructs
containing rs4782722-T (S17 Fig), suggesting that rs4782722-G is responsible for increased
transcriptional activity of a target gene leading to lower adiponectin levels. Taken together,
these data show that rs4782722 at CDH13 signal ‘B’ exhibits allelic differences in transcriptional enhancer activity and suggest it functions within a distal intron 1 cis-regulatory element,
distinct from the proximal intron 1 variants at CDH13 signal ‘A’.

Discussion
Here we described statistically distinct and independent complex trait association signals that
act through molecularly distinct mechanisms. At the ADIPOQ GWAS locus, which harbors
extensive allelic heterogeneity, seven association signals appear to act through two different
coding mechanisms (missense variant altering protein multimerization and splice variant leading to a nonfunctional transcript) and multiple transcriptional regulatory mechanisms acting
on three target transcripts, ADIPOQ and two long non-coding RNAs. At the CDH13 GWAS
locus, two signals associated with decreased plasma adiponectin levels likely act via proximal
intron 1 promoter (signal ‘A’) and distal intron 1 enhancer (signal ‘B’) variants to affect expression levels of CDH13. Using molecular-based assays, we demonstrated variants at several association signals at both the ADIPOQ and CDH13 loci are located in regulatory elements and
exhibit significant allelic effects on transcription. Identification and molecular dissection of
multiple association signals at a GWAS locus provides a more accurate measure of the
explained trait variability, enabling additional molecular mechanisms and target genes to be
identified, furthering our understanding of target gene regulation and the biology underlying
complex traits.
Allelic heterogeneity is a common characteristic of complex traits[29], and identifying multiple signals at GWAS loci serves several purposes. First, each signal can help identify which
genes influence the trait[13]. Even at loci for which an effector gene is obvious, such as ADIPOQ for adiponectin levels, each signal can help elucidate gene function and/or a regulatory
mechanism. In addition, each association signal can account for additional trait variation and
explain more trait heritability[5]. Finally, the prediction accuracy of polygenic risk scores relies
on the full set of variants that affect a trait, and including variants from multiple association
signals at a locus can improve prediction accuracy[30].
As GWAS sample sizes increase and more signals are identified, the intricacies of how to
characterize, annotate, and/or dissect multiple signals at individual loci are becoming more
apparent[4]. eQTL sample sizes are also increasing, gaining sufficient statistical power to identify and differentiate multiple signals[25]. Several methods exist for identifying multiple signals
at a GWAS locus[31, 32]. We had individual-level genotype and trait data available; therefore,
we performed exact stepwise conditional analyses. This method proved robust to different
modifications in consistently identifying the same lead variants and order in which the signals
appeared. When only summary association data are available, such as from GWAS meta-analyses, distinct signals can be detected using approximate conditional analysis with GCTA with
estimated LD from a provided reference sample[32]. When we applied GCTA using the genotype information from the GWAS study samples and METSIM as a reference for LD, GCTA
and stepwise conditional analyses yielded nearly identical results across all loci, with the exception of one very rare signal (ADIPOQ signal ‘G’). While all methods for identification of multiple association signals have limitations (e.g. computationally intensive, data availability,
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accurate representation for LD), identifying potentially novel additional signals can better capture the genetic architecture of GWAS loci.
Adiponectin is an adipose-tissue derived hormone that plays a central role in energy
homeostasis[17]. Higher levels of adiponectin can protect from obesity, type 2 diabetes, atherosclerosis, and cardiovascular disease[33]. Interaction of adiponectin with its receptors activates signaling pathways that affect insulin signaling, nitric oxide production, adipogenesis,
glucose uptake, fatty acid oxidation, lipogenesis, glycolysis, and gluconeogenesis[34]. Many
loci associated with adiponectin levels are shared with other insulin resistance traits and risk of
type 2 diabetes, including loci near IRS1, LYPAL1, ARL15/FST, VEGFA, CMIP, and PEPD[7].
The insulin-sensitizing, anti-diabetic, anti-atherogenic, and anti-inflammatory properties of
adiponectin suggest its potential relevance as a therapeutic target for diabetes and metabolic
syndrome[34].
Given the obvious biological link between the ADIPOQ gene and circulating plasma adiponectin levels, both candidate gene studies and GWAS have previously identified pronounced
associations between variants in and near ADIPOQ and adiponectin levels[35–37]. Previous
GWAS meta-analyses have consistently reported the strongest associations for variants in high
LD (r2�0.80) with signal ‘B’ from this study[20, 38]. However, these meta-analyses used genotype data imputed to the relatively sparse HapMap2 reference panel that does not include representative variants from signals ‘A’, ‘D’, ‘E’, ‘F’, or ‘G’. Similar to our observation, another
study using the denser UK10K reference panel identified stronger adiponectin association for
variants within signal ‘A’[39]. Experimental studies have also identified variants that functionally affect adiponectin levels, including rs17366653 (signal ‘E’) and rs62625753 (signal ‘G’) and
other coding variants not polymorphic or available in this study[22, 40, 41]. Our results suggest
that many statistically independent (signals ‘C’, ‘D’, ‘E’, ‘G’) and distinct (signals ‘A’, ‘B’, and
‘F’) association signals exist that act via distinct molecular mechanisms to affect adiponectin
levels. Association analyses in larger studies will likely detect additional signals and may reveal
additional potential molecular mechanisms.
ADIPOQ association signal ‘A’ was colocalized with eQTL signals for ADIPOQ and
LINC02043, while ADIPOQ association signal ‘F’ was colocalized with an eQTL for ADIPOQ-AS1, suggesting that the functional variant(s) at each signal may regulate expression of a
non-coding transcript. Very little is known about LINC02043, which was very lowly expressed,
but long non-coding RNAs can regulate nearby genes in cis through mechanisms such as transcriptional initiation, splicing, mRNA stability, translation, and the regulation of epigenetic
modifications[42, 43]. The alleles associated with decreased plasma adiponectin levels at ADIPOQ signal ‘A’ are associated with decreased expression of both ADIPOQ and LINC02043,
suggesting that LINC02043 may play a role in coordinating the regulatory activity of ADIPOQ,
although LINC02043 may simply be affected by nearby enhancers but not influence adiponectin levels. Previous work has suggested that ADIPOQ-AS1 plays a post-transcriptional role in
the regulation of ADIPOQ, inhibiting adipogenesis through the formation of an ADIPOQ-AS1/ADIPOQ mRNA complex to suppress the translation of ADIPOQ mRNA[24, 44]. In
addition, overexpression of ADIPOQ-AS1 was shown to inhibit the differentiation of preadipocytes, suggesting ADIPOQ-AS1 plays a crucial role in adipogenesis[24]. The directions of
association we observe between variants at ADIPOQ signal ‘F’ with both decreased plasma adiponectin levels and increased expression level of ADIPOQ-AS1 are consistent with this role.
Complex loci can include multiple association signals that are located close in physical position yet are independent or distinct. Some GWAS loci are relatively straightforward, with a
single association signal, functional variant, and mechanism. We demonstrate that multiple
signals within a locus may also be functionally examined separately from each other, even
when they are not statistically independent, and that multiple signals can exhibit distinct
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effects through multiple mechanisms and multiple transcripts. Full characterization of GWAS
loci with regards to signal identification, fine-mapping, and functional annotation can provide
insight into the genetic architecture of the loci and the corresponding traits.

Methods
Ethics statement
The METSIM study was approved by the Ethics Committee of the University of Eastern Finland and Kuopio University Hospital in Kuopio, Finland and carried out in accordance with
the Helsinki Declaration. Written informed consent was obtained from all participants.

Study participants
The study included 9,262 non-diabetic men from the population-based METSIM study (mean
age 57±7 SD years and BMI 26.8±3.8 kg/m2)[18].

Adiponectin measurements
All METSIM participants participated in a one-day outpatient visit to the Clinical Research
Unit at the University of Eastern Finland for data collection, which included an interview for
their medical history and a blood sample following a 12-hour fast. Plasma adiponectin was
measured using the Human Adiponectin ELISA kit (LINCO Research, St. Charles, MO, USA).

Genotyping and imputation
We genotyped the METSIM participants using the HumanOmniExpress-12v1_C BeadChip
and Infinium HumanExome-12 v1.0 BeadChip[45]. Genotypes were imputed using the HRC
reference panel[46], and separately using the GoT2D reference panel[45], a dense reference
panel of >19 million variants (SNPs, in-dels, and large deletions) based on the whole genome
sequencing of 2,657 Europeans individuals from Germany, Sweden, Finland, and Britain. Following quality control[45], we tested 16,607,452 variants for association with adiponectin.

Single-variant analysis
We tested for adiponectin association using the imputed dosages for all variants with summed
minor allele count dosage >1 assuming an additive model of inheritance and accounting for
cryptic relatedness using the EMMAX linear mixed model approach implemented in EPACTS
[47]. Circulating adiponectin levels were adjusted for BMI, age, and age2, and then residuals
were inverse normalized. Sensitivity analyses were also performed adjusting for age, age2, and
fat mass percentage; results were similar (S5 Table).

Conditional analyses
At loci that exhibited genome-wide evidence of association (P<5x10-8), we performed a series
of stepwise conditional analyses by adding the most strongly associated variant into the regression model as a covariate and testing for association with all remaining variants within 1 Mb
of the initial lead GWAS variant at each locus. At loci with genome-wide evidence of association, we set a less stringent, locus-wide significance threshold of P<1x10-5 to define additional
signals based on an approximate 5,000 tests performed at a locus.[7] We performed stepwise
conditional analyses until the strongest association variant showed a conditional P-value >
1x10-5 or had no annotation evidence that suggested a functional role. Sensitivity analyses
were also performed altering the order at which signals were included in the stepwise
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conditional analysis and altering which variant was selected as the representative for each association signal; results were similar.
We also used Genome-wide Complex Trait Analysis[32] (GCTA) approximate regression
models to identify multiple association signals at locus-wide significance (P<1x10-5) using
genotype data from 10,197 METSIM participants as the LD reference panel. Haplotype analyses were performed using Haplostats in R (https://cran.r-project.org/web/packages/haplo.
stats/index.html). We created regional association plots using LocusZoom[48]. Unless otherwise noted, all LD estimates were calculated based on the METSIM data from 10,197 individuals; reported allele frequencies were calculated based on the 9,262 individuals included in this
analysis.
We evaluated the proportion of variance explained by a single variant or any given locus by
including the variant or a set of variants into a linear regression model with all covariates used
in association analysis and calculating the R2 for the full model. We performed these analyses
using SAS version 9.4 (SAS Institute, Cary, NC, USA).

Subcutaneous adipose eQTLs
To aid in the identification of candidate genes at the most strongly associated signals, we examined whether any of the variants associated with adiponectin were also associated with expression of nearby transcripts in subcutaneous adipose tissue. The expression quantitative trait
locus (eQTL) data were generated from a subset of 434 METSIM participants with RNAsequencing data[23]. A false discovery rate (FDR) <1% was used to identify cis-eQTLs. We
also performed stepwise conditional analyses at each colocalized locus, conditioning stepwise
on the variant most strongly associated with gene expression, to identify additional eQTL signals for each transcript. GWAS and eQTL signals were considered to be colocalized when (a)
the GWAS variant and the variant most strongly associated with expression level of the corresponding transcript exhibit high pairwise LD (r2�0.80), and (b) the association of the eQTL
signal became insignificant (FDR>1%) after conditioning on the GWAS variant. For colocalization analyses with ADIPOQ signal ‘A’, we used proxy variant rs143784260 to represent
rs199938283 (r2 = 1.00; calculated in METSIM), which was not available in the cis-eQTL
dataset.

Variant annotation
To establish a set of candidate functional variants at the ADIPOQ and CDH13 loci, we used
transcriptional regulatory chromatin marks (accessible chromatin and histone modification
states) to predict which variants may affect the transcription of the nearby genes. We compiled
regulatory elements from ENCODE[49], ChromHMM[50], Roadmap Epigenomics Project
[51] data available through the UCSC Genome Browser[52], and accessible chromatin data
from adipose tissue, preadipocytes, and adipocytes[53, 54]. We defined candidate variants as
those located within accessible chromatin peaks, Roadmap ChromHMM chromatin states of
enhancers and promoters, and chromatin-immunoprecipitation sequencing (ChIP-seq) peaks
of histone modifications H3K4me1, H3K4me3, and H3K27ac, and transcription factor binding sites in adipose-derived mesenchymal stem cells and adipocyte nuclei (ADIPOQ locus)
and HeLa cells (CDH13 locus only).

Cell culture
Cell lines were selected based on expression patterns of nearby genes. Because ADIPOQ is
expressed almost exclusively in mature adipocytes[25], we used 3T3-L1 cells differentiated
into mature adipocytes for experiments with variants at the ADIPOQ locus. CDH13 is
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expressed throughout most of the tissues in the body, including vascular cells and adipose tissue[25]. Because variants at the CDH13 locus were observed to be located in accessible chromatin regions in HeLa cells, we performed experiments with these variants in HeLa cells.
3T3-L1 cells (ATCC, CL-173) were cultured and differentiated as described in the ATCC protocol. HeLa cervical cancer cells (ATCC CCL-2) were cultured in DMEM/Ham’s F-12 (Corning) supplemented with 10% FBS. All cell lines were maintained at 37˚C with 5% CO2.

Transcriptional reporter assays
We designed oligonucleotide primers (S11 Table) with KpnI and XhoI restriction sites. Using
Q5 High-Fidelity DNA Polymerase (New England BioLabs), we PCR-amplified fragments surrounding each variant from DNA of individuals homozygous for each allele and cloned the
PCR product into the multiple cloning site of a minimal promoter firefly luciferase reporter
vector (pGL4.23, Promega) in both orientations with respect to the reporter gene. For CDH13
signal ‘B’, rs4782722 in the 398 bp construct was altered to create missing haplotypes using the
QuikChange II Site Directed Mutagenesis Kit (Agilent Technologies). Three to five isolated
clones for each allele for each orientation were sequenced to verify genotype. Cells were seeded
with approximately 2×105 (3T3-L1) or 6×105 (HeLa) cells per well in 24-well plates. Each
clone was co-transfected with Renilla luciferase vector (phRL-TK, Promega) in duplicate
(HeLa) or triplicate (differentiated 3T3-L1) using Lipofectamine 2000 (Life Technologies)
according to manufacturer’s recommendations. After 48 hours transfection, we lysed cells
with passive lysis buffer (Promega) and measured luciferase activity using the Dual-Luciferase
Reporter Assay System (Promega). We normalized firefly luciferase readings to Renilla luciferase readings and normalized all readings to the average of two empty pGL4.23 vector transfections. We used 2-sided Student’s t-tests to compare allelic differences in firefly luciferase
activity. All transfections were repeated independently and yielded comparable results.

Electrophoretic mobility shift assay (EMSA)
We designed 17-bp biotin-labeled and unlabeled complementary oligonucleotide probes for
both rs76071583 alleles (S11 Table). As previously described[55], using the LightShift Chemiluminescent EMSA Kit (Thermo Fisher Scientific), 300 femtomole of biotin-labeled doublestranded oligos were incubated with 450 ng recombinant CEBP-a protein (Creative Biomart
CEBPA-153H). To test the specificity of the protein complexes to the allele, 50x excess unlabeled probes were added to the binding reactions. We repeated EMSA experiments on independent days and obtained consistent results.

Supporting information
S1 Fig. Manhattan plot for the genome-wide association study of plasma adiponectin levels
from 9,262 participants in the Metabolic Syndrome in Men (METSIM) study. Plasma adiponectin levels were inverse normal transformed following adjustment for age, age2, and BMI.
-log10(P-values) of association results are plotted against hg19 genomic coordinates. Loci
achieving genome-wide significance are labeled and include IRS1, PBRM1, ADIPOQ, and
CDH13. A potentially novel adiponectin locus on chromosome 3, EPHA3, was also identified,
but the only genome-wide significant variant, rs139269730, had moderate imputation quality
(r2 = 0.74) and may represent a false positive (see S6 Fig), thus, this locus was excluded from
further analyses.
(TIF)
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S2 Fig. Adiponectin locus near CDH13 exhibits two association signals. (A) The purple diamond represents rs12051272, the strongest associated variant in the initial unconditioned
analysis of plasma adiponectin. Other variants are colored based on LD with the lead variant
within the METSIM subjects. (B) After conditioning on rs12051272, an additional signal,
rs4782722, persisted. (C) No additional association signals persisted after conditioning on
rs12051272 and rs4782722.
(TIF)
S3 Fig. Adiponectin locus near ADIPOQ exhibits seven association signals. (A) The purple
diamond represents rs199938283, the strongest associated variant in the initial unconditioned
analysis of plasma adiponectin at this locus. Other variants are colored based on LD with the
lead variant within the METSIM subjects. (B) After conditioning on rs199938283, the lead
adiponectin-associated variant is rs4632532. (C) After conditioning on rs199938283 and
rs4632532, an additional signal with lead variant rs16861209, persisted. (D) After conditioning on rs199938283, rs4632532, and rs16861209, an additional signal with lead variant
rs73187787, persisted. (E) After conditioning on rs199938283, rs4632532, rs16861209, and
rs73187787, an additional signal with lead variant rs17366653, persisted. (F) After conditioning on rs199938283, rs4632532, rs16861209, rs73187787, and rs17366653, an additional signal
with lead variant rs17846866, persisted. (G) After conditioning on rs199938283, rs4632532,
rs16861209, rs73187787, rs17366653, and 17846866, an additional signal, rs62625753, persisted. (H) No additional association signals persisted after conditioning on rs199938283,
rs4632532, rs16861209, rs73187787, rs17366653, rs17846866, and rs62625753. Y-axis scale
varies between panels to best show the results of each analysis.
(TIF)
S4 Fig. Adiponectin locus near IRS1 exhibits one association signal. (A) The purple diamond represents rs149689033, the strongest associated variant at this locus. Other variants are
colored based on LD with the lead variant within the METSIM subjects. (B) After conditioning
on rs149689033, no additional association signals persisted.
(TIF)
S5 Fig. Adiponectin locus near PBRM1 exhibits one association signal. (A) The purple diamond represents rs2276824, the strongest associated variant at this locus. Other variants are
colored based on LD with the lead variant within the METSIM subjects. (B) After conditioning
on rs2276824, no additional association signals persisted.
(TIF)
S6 Fig. Adiponectin locus near EPHA3 exhibits one association signal. (A) The purple diamond represents rs139269730, the strongest associated variant at this locus (rs139269730-T:
β = -0.243, SE = 0.044, P = 4.1x10-8, effect allele frequency = 0.74). Other variants are colored
based on LD with the lead variant within the METSIM subjects. (B) After conditioning on
rs139269730, no additional association signals persisted. The ~3 Mb gap in variants observed
in the plots represents the centromere of chromosome 3. The only genome-wide significant
variant had moderate imputation quality (r2 = 0.74) and may represent a false positive, thus,
this locus was excluded from further analyses.
(TIF)
S7 Fig. Location of candidate variants at ADIPOQ. The lead adiponectin-associated variants
at ADIPOQ signals A-G (excluding signal ‘D’) and variants in high LD (r2�0.80) are shown.
Variants representing signal ‘A’ are shown in red, signal ‘B’ in magenta, signal ‘C’ in green,
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signal ‘E’ in navy, signal ‘F’ in brown, and signal ‘G’ in dark purple.
(TIF)
S8 Fig. Adiponectin haplotype association analysis for ADIPOQ lead variants that are not
independent (LD r2>.01). Haplotypes were constructed in 9,262 participants from the METSIM study using the lead variant of each association signal using HaploStats. ‘Count’ indicates
the number of estimated haplotypes. (A) Haplotypes for association signals ‘A’ and ‘B’. (B)
Haplotypes for association signals ‘A’ and ‘F’. Haplotypes with the same allele for any given signal (e.g. signal ‘A’) show different effect sizes (betas) consistent with their single variant results
for alleles at the other signals (e.g. B, F). Alleles associated with lower adiponectin are shown in
purple while alleles associated with higher adiponectin are shown in green. Haplotype association was performed with adiponectin inverse normalized residuals after adjusting for age, age2,
and BMI using the haplotype containing the adiponectin-increasing alleles at all seven signals
as the reference.
(TIF)
S9 Fig. Adiponectin haplotype association analysis at ADIPOQ in the 9,262 participants
from the METSIM study. A) Haplotype of all adiponectin-increasing alleles used as the baseline reference. B) Haplotype with the largest sample size used as the baseline reference (same
as the baseline reference haplotype used in S10 Fig). Haplotypes with the same allele for any
given signal (e.g. signal ‘A’) show different effect sizes (betas) consistent with their single variant results for alleles at the other signals (e.g. B, C, etc). Haplotypes were constructed with the
lead variant of each association signal using HaploStats. ‘Count’ indicates the number of estimated haplotypes. Alleles associated with lower adiponectin are shown in purple while alleles
associated with higher adiponectin are shown in green. Haplotype association was performed
with adiponectin inverse normalized residuals after adjusting for age, age2, and BMI using the
haplotype containing the adiponectin-increasing alleles at all seven signals as the reference.
The dashed line divides common haplotypes from rare (haplotype frequency <0.001.
(TIF)
S10 Fig. Adiponectin haplotype association analysis in the 5,274 participants from the
METSIM study who are homozygous for all seven ADIPOQ association signals. Haplotypes
were constructed with the lead variant of each association signal using HaploStats. ‘Count’
indicates the number of estimated haplotypes. Alleles associated with lower adiponectin are
shown in purple while alleles associated with higher adiponectin are shown in green. Haplotype association was performed with adiponectin inverse normalized residuals after adjusting
for age, age2, and BMI using the most prevalent haplotype as the reference. The order of haplotype effect sizes is consistent with the order of haplotype effect sizes for all 9,262 study participants shown in S9 Fig.
(TIF)
S11 Fig. Distribution of expression levels for ADIPOQ (A), ADIPOQ-AS1 (B), and
LNC02043 (C) in subcutaneous adipose tissue from 434 males from the METSIM study.
Expression levels are stratified by genotype for the variant most strongly associated with each
transcript (eQTL): rs143784260 (A and C) and rs17846866 (B). The lead adiponectin GWAS
variant for signal ‘A’, rs199938283, was not available in the eQTL dataset; however, the lead
eQTL variant rs143784260 is in perfect LD (r2 = 1.00). For each transcript, expression levels
are presented in transcript per million (TPMs) on the left and normalized TPMs after PEER
correction on the right.
(TIF)
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S12 Fig. Comparison of expression levels of ADIPOQ, ADIPOQ-AS1, and LNC02043. Correlations between expression levels of ADIPOQ and ADIPOQ-AS1 (A) or ADIPOQ and
LNC02043 (B) are shown using transcripts per million (TPM) values in the left plot and normalized TPMs after correction for PEER factors on the right. Pearson correlation (R2) values
and corresponding P-values are displayed for each plot. (C) Before normalization, the distribution of TPM values is much wider for ADIPOQ (approximate range 0–2500) than for either
ADIPOQ-AS1 (approximate range 0–27) or LNC02043 (0–3.5). The upper right plot in (C) is a
zoomed-in version of the plot on the left. Following PEER factor correction and inverse normal transformation, TPM values are evenly distributed between the three transcripts (bottom
right plot); these values were used in eQTL analyses.
(TIF)
S13 Fig. Haplotype association analysis for expression levels of three transcripts in 434
participants from the METSIM study. Haplotypes are shown for expression of (A) ADIPOQ,
(B) ADIPOQ-AS1, and (C) LNC02043. Expression levels are shown in transcripts per million
(TPMs) for plots on the left and normalized TPMs after PEER correction on the right. Haplotypes with the same allele for any given signal (e.g. signal ‘A’) show different effect sizes (betas)
consistent with their single variant results for alleles at the other signals (i.e. ‘F’). Haplotypes
were constructed with the lead variant of each association signal using HaploStats. ‘Count’
indicates the number of estimated haplotypes. Alleles associated with lower expression are
shown in purple, while alleles associated with higher expression are shown in green.
(TIF)
S14 Fig. Additional candidate variants from ADIPOQ signals ‘A’ and ‘B’ did not exhibit
allelic differences in transcriptional activity in differentiated 3T3L1 adipocytes. (A)
rs150411458 for signal ‘A’. (B) A haplotype of four variants rs1648705 (signal ‘B’), rs4632532
(signal ‘B’), rs1648707 (signal ‘B’), and rs143257534 (signal ‘A’). (C) A haplotype of two variants rs4632532 (signal ‘B’) and rs1648707 (signal ‘B’).
(TIF)
S15 Fig. CEBP-α binds to rs76071583 to increase enhancer activity. Electromobility shift
assay (EMSA) with biotin-labeled probes containing the A or G allele of rs76071583 and
purified CEBPA protein show an allele-specific band (lane 6 versus lane 2) that is competed
away more effectively by 50-fold excess of unlabeled probe containing the A allele (lane 7)
than the G allele (lane 8). An arrow points to an allele-specific protein complex binding to
the A allele.
(TIF)
S16 Fig. CDH13 signal A candidate variants and replicated experiments. (A) Positions of
the lead adiponectin-associated GWAS variant in this study, rs12051272, and seven proxy variants (r2�0.80; “EUR Candidates”) are shown. (B) Adiponectin genome-wide association
results from the METSIM study shown with East Asian LD (1000 Genomes Phase 3) and
METSIM LD. The reported lead variant associated with adiponectin in East Asians is
rs4783244 is in strong LD with rs12051272 in East Asian populations (r2 = 0.92) but not in
Finns(r2 = 0.05). (C) Results from replicated transcriptional activity experiments of CDH13
signal ‘A’ show rs12051272-G is consistently associated with greater transcriptional activity in
both the forward and reverse orientations with respect to CDH13 in HeLa cells compared to
rs12051272-T and an “empty vector” containing a minimal promoter. Using a linear regression model to analyze data from all three transcriptional activity experiments provides further
support that rs12051272-G is associated with greater transcriptional activity in both the
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forward (P = 0.02) and reverse (P = 0.004) directions.
(TIF)
S17 Fig. The second signal at CDH13 (signal ‘B’) exhibits allelic differences in transcriptional activity. (A) rs4782722 and all five candidate variants in high pairwise LD (r2�0.80)
span a 2.5 kb region in CDH13 introns 1 and 2. (B) At CDH13 signal ‘B’, additional haplotypes
of rs4782722 and rs12444113 created by site-directed mutagenesis of rs4782722 implicate
rs4782722 as a regulatory variant. Transcriptional reporter assays of a regulatory region spanning rs4782722 and rs12444113 in HeLa cells show that haplotypes containing rs4782722-G
(GG and GC) exhibited greater transcriptional activity than haplotypes containing
rs4782722-T (TG and TC) in the forward and reverse orientations. Each dot represents transcriptional activity of an independent experimental clone.
(TIF)
S18 Fig. rs3910232 at CDH13 signal ‘B’ does not exhibit allelic differences in transcriptional activity in HeLa cells. rs3910232 is a proxy of rs4782722 but does not appear to contribute to transcriptional activity differences at this locus.
(TIF)
S1 Table. METSIM association results (P<0.05) for previously reported adiponectin-associated variants.
(XLSX)
S2 Table. GWAS signals of adiponectin association at locus-wide significance using
sequential conditional analysis.
(XLSX)
S3 Table. METSIM linkage disequilibrium values between identified signals at ADIPOQ.
(XLSX)
S4 Table. Adiponectin-association results in METSIM at ADIPOQ coding variants.
(XLSX)
S5 Table. Sensitivity analysis comparing adiponectin-associated GWAS loci across reference panels and adjustments at locus-wide significance using sequential conditional analysis.
(XLSX)
S6 Table. Colocalization of adiponectin GWAS signals and subcutaneous adipose ciseQTLs (RNA-seq, n = 434).
(XLSX)
S7 Table. ADIPOQ GWAS variant eQTL associations in METSIM subcutaneous adipose
(n = 434) for transcripts surrounding ADIPOQ.
(XLSX)
S8 Table. Interrogation of subcutaneous adipose eQTLs for adiponectin-associated variants at the ADIPOQ locus in GTEx (July 2, 2019).
(XLSX)
S9 Table. Reciprocal conditional analysis of adiponectin GWAS signals ‘A’ and ‘F’ at ADIPOQ and cis-eQTLs for ADIPOQ and ADIPOQ-AS1 (RNA-seq, n = 434).
(XLSX)
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S10 Table. Adiponectin association results in METSIM at CDH13 coding variants.
(XLSX)
S11 Table. Primer sequences used in functional assays.
(XLSX)

Acknowledgments
We thank the METSIM study participants, Peter Chines for his contributions to METSIM genotyping, Martin Buchkovich for his assistance with the UCSC Genome Browser, and Victoria
Parsons for critical review of the manuscript. We also acknowledge ENCODE and the NIH
Roadmap Epigenomics Consortia for chromatin state data.

Author Contributions
Conceptualization: Cassandra N. Spracklen, Francis S. Collins, Michael Boehnke, Markku
Laakso, Karen L. Mohlke.
Data curation: Cassandra N. Spracklen, Anne U. Jackson, Heather M. Stringham, Markku
Laakso.
Formal analysis: Cassandra N. Spracklen, Anne U. Jackson, Sarah M. Brotman, Ying Wu,
Kevin W. Currin, Hannah J. Perrin.
Funding acquisition: Cassandra N. Spracklen, Päivi Pajukanta, Francis S. Collins, Michael
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